Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis
- 1 November 2010
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 67 (11), 1329-1335
- https://doi.org/10.1001/archneurol.2010.150
Abstract
Research from JAMA Neurology — Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis — Eight-Year Follow-upKeywords
This publication has 16 references indexed in Scilit:
- Disability as an outcome in MS clinical trialsNeurology, 2008
- Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple SclerosisArchives of Neurology, 2006
- Natural history of multiple sclerosis: a unifying conceptBrain, 2006
- Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patientsMultiple Sclerosis Journal, 2005
- Relapses and Progression of Disability in Multiple SclerosisThe New England Journal of Medicine, 2000
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patientsMultiple Sclerosis Journal, 1995
- Design strategies in multiple sclerosis clinical trialsAnnals of Neurology, 1994
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- COURSE AND PROGNOSIS OF MULTIPLE SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA PROCESSING OF 349 PATIENTSBrain, 1980